2-[2-(2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid
AlkaPlorer ID: AK579338
Synonym: None
IUPAC Name: (2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid
Structure
SMILES: CSCC[C@H](N=C(O)[C@H](CC1=CC=CC=C1)N=C(O)CN=C(O)CN=C(O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)O
InChI: InChI=1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1
InChIKey: YFGBQHOOROIVKG-FKBYEOEOSA-N
Reference
Isolation of molluscan opioid peptides
PubChem CID: 162639989
CAS: 58569-55-4
LOTUS: LTS0113875
Source
Properties Information
Molecule Weight: 573.6720000000005
TPSA?: 213.91
MolLogP?: 2.9056000000000006
Number of H-Donors: 7
Number of H-Acceptors: 8
RingCount: 2
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Cavia porcellus | Cavia porcellus | Activity | 100.0 | % | 10.1021/jm00177a016 |
| Cavia porcellus | Cavia porcellus | IC50 | 200.0 | nM | 10.1021/jm00118a005 |
| Cavia porcellus | Kappa opioid receptor | IC50 | 10000.0 | nM | 10.1016/S0960-894X(01)81068-4 |
| Cavia porcellus | Kappa opioid receptor | Ki | 4467.0 | nM | 10.1016/j.bmcl.2006.05.060 |
| Cavia porcellus | Mu opioid receptor | IC50 | 200.0 | nM | 10.1021/jm00142a002 |
| Cavia porcellus | Mu opioid receptor | Ki | 6.9 | nM | 10.1016/j.bmcl.2006.05.060 |
| Cavia porcellus | Nociceptin receptor | Ki | 277.0 | nM | 10.1016/j.bmcl.2006.05.060 |
| Danio rerio | Mu opioid receptor-like OR2 | Ki | 684.0 | nM | 10.1016/j.bmc.2017.02.052 |
| Danio rerio | Opioid receptor, delta 1b | Ki | 45.0 | nM | 10.1016/j.bmc.2017.02.052 |
| Danio rerio | Opioid receptor homologue | Ki | nan | None | 10.1016/j.bmc.2017.02.052 |
| Homo sapiens | Caco-2 | Inhibition | 3.2 | % | 10.1021/jm051026+ |
| Homo sapiens | Caco-2 | Inhibition | 4.2 | % | 10.1021/jm051026+ |
| Homo sapiens | Caco-2 | Inhibition | 6.4 | % | 10.1021/jm051026+ |
| Homo sapiens | Caco-2 | Inhibition | 8.4 | % | 10.1021/jm051026+ |
| Homo sapiens | Delta opioid receptor | EC50 | 1.03 | nM | 10.1016/j.bmc.2011.11.047 |
| Homo sapiens | Delta opioid receptor | EC50 | 1.03 | nM | 10.1016/j.bmcl.2009.03.099 |
| Homo sapiens | Delta opioid receptor | EC50 | 47.0 | nM | 10.1016/j.bmcl.2007.01.092 |
| Homo sapiens | Delta opioid receptor | IC50 | 6.4 | nM | 10.1021/acs.jmedchem.5b01170 |
| Homo sapiens | Delta opioid receptor | Ki | 1.1 | nM | 10.1016/j.bmcl.2006.05.060 |
| Homo sapiens | Delta opioid receptor | Ki | 2.0 | nM | 10.1016/j.bmcl.2007.01.092 |
| Homo sapiens | HBL | Inhibition | 0.4 | % | 10.1021/jm051026+ |
| Homo sapiens | HBL | Inhibition | 1.0 | % | 10.1021/jm051026+ |
| Homo sapiens | HBL | Inhibition | 4.5 | % | 10.1021/jm051026+ |
| Homo sapiens | HBL | Inhibition | 10.8 | % | 10.1021/jm051026+ |
| Homo sapiens | HeLa | Inhibition | 2.3 | % | 10.1021/jm051026+ |
| Homo sapiens | HeLa | Inhibition | 11.4 | % | 10.1021/jm051026+ |
| Homo sapiens | HeLa | Inhibition | 12.0 | % | 10.1021/jm051026+ |
| Homo sapiens | HeLa | Inhibition | 22.3 | % | 10.1021/jm051026+ |
| Homo sapiens | HEp-2 | Inhibition | 2.4 | % | 10.1021/jm051026+ |
| Homo sapiens | HEp-2 | Inhibition | 3.3 | % | 10.1021/jm051026+ |
| Homo sapiens | HEp-2 | Inhibition | 4.5 | % | 10.1021/jm051026+ |
| Homo sapiens | HEp-2 | Inhibition | 5.2 | % | 10.1021/jm051026+ |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -7.67 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -7.34 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HT-29 | Inhibition | 14.0 | % | 10.1021/jm051026+ |
| Homo sapiens | HT-29 | Inhibition | 15.9 | % | 10.1021/jm051026+ |
| Homo sapiens | HT-29 | Inhibition | 16.1 | % | 10.1021/jm051026+ |
| Homo sapiens | HT-29 | Inhibition | 19.3 | % | 10.1021/jm051026+ |
| Homo sapiens | Kappa opioid receptor | Ki | 10000.0 | nM | 10.1016/j.bmcl.2007.01.092 |
| Homo sapiens | MCF7 | Inhibition | 3.6 | % | 10.1021/jm051026+ |
| Homo sapiens | MCF7 | Inhibition | 4.1 | % | 10.1021/jm051026+ |
| Homo sapiens | MCF7 | Inhibition | 7.6 | % | 10.1021/jm051026+ |
| Homo sapiens | MCF7 | Inhibition | 15.4 | % | 10.1021/jm051026+ |
| Homo sapiens | Mu opioid receptor | Activity | 100.0 | % | 10.1016/j.bmcl.2021.127790 |
| Homo sapiens | Mu opioid receptor | Activity | nan | None | 10.1074/jbc.m703272200 |
| Homo sapiens | Mu opioid receptor | EC50 | 620.0 | nM | 10.1016/j.bmcl.2007.01.092 |
| Homo sapiens | Mu opioid receptor | IC50 | 13.0 | nM | 10.1021/acs.jmedchem.5b01170 |
| Homo sapiens | Mu opioid receptor | Ki | 19.0 | nM | 10.1016/j.bmcl.2007.01.092 |
| Homo sapiens | Regulator of G-protein signaling 4 | Potency | 8436.8 | nM | None |
| Homo sapiens | SW-620 | Inhibition | 12.7 | % | 10.1021/jm051026+ |
| Homo sapiens | SW-620 | Inhibition | 15.3 | % | 10.1021/jm051026+ |
| Homo sapiens | SW-620 | Inhibition | 18.9 | % | 10.1021/jm051026+ |
| Homo sapiens | SW-620 | Inhibition | 19.1 | % | 10.1021/jm051026+ |
| Mus musculus | Delta opioid receptor | IC50 | 13.0 | nM | 10.1021/jm00142a002 |
| Mus musculus | Mus musculus | ED50 | 7e-07 | M mouse-1 | 10.1016/S0960-894X(01)81068-4 |
| Mus musculus | Mus musculus | IC50 | 13.0 | nM | 10.1021/jm00118a005 |
| Rattus norvegicus | Delta opioid receptor | IC50 | 1.0 | nM | 10.1016/S0960-894X(01)81068-4 |
| Rattus norvegicus | Delta opioid receptor | Ki | 7.3 | nM | 10.1021/jm00118a005 |
| Rattus norvegicus | Mu opioid receptor | EC50 | 304.0 | nM | 10.1021/jm4008592 |
| Rattus norvegicus | Mu opioid receptor | EC50 | 309.03 | nM | 10.1021/jm4008592 |
| Rattus norvegicus | Mu opioid receptor | Emax | 205.3 | % | 10.1021/jm4008592 |
| Rattus norvegicus | Mu opioid receptor | IC50 | 2.0 | nM | 10.1016/S0960-894X(01)81068-4 |
| Rattus norvegicus | Mu opioid receptor | Ki | 20.0 | nM | 10.1021/jm00043a007 |
| Rattus norvegicus | Mu opioid receptor | Ki | 27.5 | nM | 10.1021/jm00118a005 |
| Rattus norvegicus | Opioid receptor | Activity | 100.0 | % | 10.1021/jm00177a016 |
| Rattus norvegicus | Opioid receptor | IC50 | 18.0 | nM | 10.1021/jm00143a007 |
| Rattus norvegicus | Opioid receptor | IC50 | 90.0 | nM | 10.1021/jm00205a003 |
| Rattus norvegicus | Opioid receptor | IC50 | 240.0 | nM | 10.1021/jm00143a007 |
| Rattus norvegicus | Opioid receptors; mu & delta | Ratio | 0.27 | None | 10.1021/jm00118a005 |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1016/j.bmc.2019.115184 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 10.46 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 16.38 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -13.83 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.02 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.07 | % | 10.6019/CHEMBL4495565 |
| None | ADMET | Stability | nan | % | 10.1016/j.bmc.2019.115184 |
| None | Unchecked | Ki | 49500.0 | nM | 10.1021/jm00368a002 |
| None | Unchecked | Ratio | 0.065 | None | 10.1021/jm00118a005 |
| None | Unchecked | Ratio | 15.0 | None | 10.1021/jm00142a002 |
| None | Unchecked | Ratio IC50 | 2.0 | None | 10.1021/acs.jmedchem.5b01170 |
| None | Unchecked | Ratio Ki | 9.5 | None | 10.1016/j.bmcl.2007.01.092 |
